Tim Cernak, a professor of medicinal chemistry and chemistry, is being recognized for his research program ...
Ira Remsen, founding faculty member at Johns Hopkins University, established the US’s first graduate program in chemistry ...
F2G and Shionogi’s olorofim met its goals in a late-stage study, setting the stage for an FDA filing this year ...
A ruthenium-based reaction exploits the stronger carbon-deuterium bond to enrich one mirror-image form from a racemic mixture ...
Called Cas12a2, the CRISPR system had some distinctive properties. Rather than editing cells’ DNA when prompted by a guide RNA, as CRISPR-Cas9 does, Cas12a2 indiscriminately shreds it, ultimately ...
Biotechs in the US and Europe face challenges, but as a recent panel discussion made clear, the competition offers global ...
Estuary Biotherapeutics, which is developing gene therapies to treat kidney disease, has launched with $103 million in ...
The advance opens up potential therapeutic uses for clearing unwanted proteins ...
Mixing an electrochemically active cathode material powder (left) with a new fluorine-free binder (middle) and a nontoxic ...
HydRegen’s scientists are commercializing hydrogenase systems that work in conventional chemical reactors. Credit: HydRegen Enzymes are powerful tools for chemical synthesis, but their natural setting ...
Over $1 billion sat unused in US National Science Foundation (NSF) accounts as fiscal 2026 came to a close Oct. 1. A White ...
In a recent related study, researchers in China also developed a heterogeneous hydroformylation catalyst based on rhodium.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results